COMMUNIQUÉS West-GlobeNewswire

Elite Asia Group Unveils New Integrative Wellness Approach Combining Traditional Chinese Medicine and AI Technology
18/09/2026
HONG KONG, Sept. 19, 2026 (GLOBE NEWSWIRE) -- Elite Asia Group has announced the launch of its integrative wellness center, which combines the principles of Traditional Chinese Medicine (TCM) with modern technological [...]
Amneal Announces FDA Approval and Launch of Lanreotide Injection
18/09/2026
- Expands complex injectables portfolio with important long-acting oncology treatment - Immediate commercial launch supported by in-house production BRIDGEWATER, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Amneal [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
18/09/2026
PALO ALTO, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/09/2026
FOSTER CITY, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/09/2026
WALTHAM, Mass., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update
18/09/2026
CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to engage with industry, investors and scientific leaders during a concentrated week in Boston TORONTO and HAIFA, Israel, Sept. 18, 2026 (GLOBE NEWSWIRE) -- [...]
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
18/09/2026
In a post hoc analysis of the open-label safety stage of the Phase 3 SOLARIS trial, more than half of participants receiving TEV-'749 achieved stabilization, few relapsed and more than one-fifth of participants [...]
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs
18/09/2026
New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables in schizophrenia, as well as oral antipsychotics in bipolar I disorder (BD-I) The new real-world data also show that [...]
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
18/09/2026
New data revealed that healthcare providers prioritize drowsiness risk, duration of available data demonstrating long-term response and drug-drug interaction profile when selecting a treatment for tardive dyskinesia (TD [...]
Johns Hopkins USFHP is One of the Highest-Rated Health Plans in the Nation
18/09/2026
TRICARE Prime® Option Earns 4.5/5 in NCQA’s 2026 Ratings HANOVER, Md., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins US Family Health Plan (USFHP) was recognized with an overall rating of 4.5 out of 5 in the National [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
18/09/2026
SAN CARLOS, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel [...]
Orion Corporation: Acquisition of own shares during week 38, 2026
18/09/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES 18/09/2026 at 19.00 EEST Orion Corporation: Acquisition of own shares during week 38, 2026 The share buybacks form part of the share buyback [...]
City of New Rochelle’s Initiative with AGZA and Quiet Communities Aims to Create Quieter, Healthier Neighborhoods
18/09/2026
Comprehensive program will help the city, landscaping businesses and residents transition from gas-powered landscape equipment to cleaner, quieter battery-electric alternatives LINCOLN, Mass., Sept. 18, 2026 (GLOBE [...]
Why Implant Position Matters Long After Surgery: A Peoria Prosthodontic Perspective
18/09/2026
A Peoria prosthodontic practice explains why implant position, bone, bite, and the final restoration need to be planned together, especially in complex, full-arch, and revision cases. Peoria, AZ, Sept. 18, 2026 (GLOBE [...]
Velocity Clinical Research appoints Justin Starzyk as Chief Executive Officer
18/09/2026
Justin brings more than two decades of experience as a healthcare operator, with a track record of scaling multisite services businesses and delivering strong outcomes for investors Paul Evans continues as Chair of the [...]
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
18/09/2026
Investigational New Drug application planned for submission to the U.S. FDA in the fourth quarter of 2026, advancing the Company’s regulatory path toward NDA filing for gout program XRx-026 CALGARY, Alberta, Sept. 18, [...]
TOMI Environmental Solutions Reports Accelerating Growth in SteraMist Service Revenue
18/09/2026
Year-to-date SteraMist iHP Service and Support sales of approximately $1.7 million reflects a roughly 31% increase over full-year 2025, underscoring the growing recurring-revenue contribution of TOMI's contracted [...]
OneMedNet Reports Record Bookings as Faster Fulfillment Begins
18/09/2026
Year-to-date bookings of $16.2 million include a combination of fit-for-purpose multi-modal datasets, datasets-plus-license arrangements, and multi-year platform access licenses; a significant portion of these bookings [...]
Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
18/09/2026
Allowed claims cover compositions and methods for preventing or mitigating stress-induced behavioral responses SARASOTA, FLA., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a [...]

Pages